Background The incidence of venous thromboembolism (VT) in neurosurgical practice is
astonishingly high, representing a major cause of morbidity and mortality. Prophylaxis …

Background Venous thromboembolism (VTE) is an important complication of neurosurgery.
Current guidelines recommend pharmacologic prophylaxis in this setting with either …

Background In neurosurgical patients, the risk of developing venous thromboembolism
(VTE) is high due to the relatively long duration of surgical interventions, usually long …

Objective To analytically discuss some protocols in Deep vein thrombosis (DVT)/pulmonary
Embolism (PE) prophylaxis currently use in Neurosurgical Departments around the world …

Although there are numerous publications addressing venous thromboembolism and its
prevention in neurosurgery, there are relatively few high-quality studies to guide decisions …

Background Compression stockings are recommended for prophylaxis against venous
thromboembolism in patients undergoing neurosurgery, but anticoagulant agents have not …

BACKGROUND: Annually, 2 million people in the United States develop deep venous
thrombosis (DVT), and nearly 100000 sustain fatal pulmonary emboli. Prophylaxis against …

BACKGROUND Pharmacological prophylaxis for venous thromboembolism (VTE) in the
neurosurgical population is still a matter of debate, as the risk-to-benefit ratio is not well …

Background Venous thromboembolism (VTE) remains the single most important preventable
cause of morbidity and mortality following neurosurgical procedures, with an incidence of …

Venous thromboembolism (VTE) events are frequent in neurooncological patients in
perioperative period thus increasing mortality and morbidity. The role of prophylaxis has not …